Related Experiment Videos

[Neonatal screening for sickle cell disease in the Consorci Sanitari de Mataro. Rationale and first results]

A Cabot Dalmau1, M Casado Toda, J Barberán Pérez

  • 1Servicio de Pediatria, Consorci Sanitari de Mataró, Barcelona.

Insights

Neonatal screening for sickle cell disease (SCD) is crucial for early detection in newborns. Hemoglobin electrophoresis is an effective method for identifying SCD in at-risk populations.

Area of Science:

  • Hematology
  • Genetics
  • Public Health

Context:

  • Sickle cell disease (SCD) is a significant health concern, particularly in populations with African ancestry.
  • Neonatal screening allows for early identification of infants with SCD.
  • Early intervention and prophylactic measures can reduce SCD-related mortality.

Purpose:

  • To evaluate the feasibility and preliminary results of neonatal screening for SCD in an immigrant population from Sub-Saharan Africa.
  • To determine the prevalence of sickle cell gene and disease in this specific demographic.

Summary:

  • A neonatal screening program utilizing alkaline and acid hemoglobin electrophoresis was conducted on 82 black neonates of Sub-Saharan African origin.
  • Preliminary findings indicate a sickle cell gene prevalence of 10.98% and a sickle cell disease prevalence of 1.22% in the screened population.
  • The observed disease prevalence was slightly lower than anticipated.

Impact:

  • Neonatal screening for SCD is essential for the black immigrant population.
  • Alkaline and acid hemoglobin electrophoresis are validated and appropriate techniques for SCD screening.
  • Early detection through screening facilitates timely management, potentially improving health outcomes for affected infants.
Abstract

Related Concept Videos